Fleischner Society pulmonary nodule recommendations

Changed by Daniel J Bell, 1 Aug 2018

Updates to Article Attributes

Title was changed:
Fleischner societySociety pulmonary nodule recommendations
Body was changed:

The Fleischner societySociety pulmonary nodule recommendations are for the follow-up and management of pulmonary nodules detected incidentally on imaging. The guideline does not apply to patients <35 years or with a history of cancer or immunosuppression. The initial guideline was released in 2005 1, subsequently separate guideline for the management of subsolid nodules released in 2013 2. New revised 2017 recommendations for incidentally found solid and subsolid nodule or nodules have since been released 4.

2017 guidelines

Solid nodules
Solitary

Solitary nodule size: <6 mm

  • low risk patients: no follow-up needed
  • high risk patients: optional CT at 12 months

Solitary nodule size: 6-8 mm

  • low risk patients: follow-up at 6-12 months, then consider further follow-up at 18-24 months
  • high risk patients: initial follow-up CT at 6-12 months and then at 18-24 months if no change

Solitary nodule size: >8 mm

  • either low or high risk patients
    • consider follow-up CT at 3 months, and/or CT-PET, and/or biopsy
Multiple

Multiple nodules size: <6 mm

  • low risk patients: no routine follow-up
  • high risk patients: optional CT at 12 months

Multiple nodules size: 6-8 mm

  • low risk patients: follow-up at 3-6 months, then consider further follow-up at 18-24 months
  • high risk patients: follow-up at 3-6 months, then at 18-24 months if no change

Multiple nodules size: >8 mm

  • low risk patients: follow-up at 3-6 months, then consider further follow-up at 18-24 months
  • high risk patients: follow-up at 3-6 months, then at 18-24 months if no change

Note: newly detected indeterminate nodule in persons 35 years of age or older

  • low risk patients: minimal or absent history of smoking and or other known risk factors
  • high risk patients: history of smoking or of other known risk factors (e.g. first degree relative with lung cancer, or exposure to asbestos, radon, uranium)
  • if a nodule up to 8 mm is partly solid or is ground glass further follow-up is required after 24 months to exclude possible slow growing adenocarcinoma (BAC) 
Subsolid nodules
Solitary pure ground-glass nodule
  • nodule size <6 mm
    • no CT follow-up required
  • nodule size ≥6 mm
    • follow up CT at 6-12 months, then every 2 years until 5 years
Solitary part-solid nodule
  • nodule size <6 mm
    • no CT follow-up required
  • nodule size ≥6 mm
    • follow-up CT at 3-6 months
    • if unchanged, and solid component remains <6mm, then annual follow-up for 5 years
Multiple subsolid nodules
  • nodule size <6 mm
    • follow-up CT at 3-6 months
    • consider further follow-up at 2 and 4 years if stable
  • nodule size ≥6 mm
    • follow-up CT at 3-6 months
    • subsequent management based on the most suspicious nodule(s)

Old guidelines

Old guidelines have been left in place in this article in case previous reported follow-up under them.

Solid nodules

Nodule size: ≤4 mm

  • low risk patients: no follow-up needed
  • high risk patients: follow-up at 12 months and if no change, no further imaging needed

Nodule size: 4-6 mm

  • low risk patients: follow-up at 12 months and if no change, no further imaging needed
  • high risk patients: initial follow-up CT at 6-12 months and then at 18-24 months if no change

Nodule size: >6-8 mm

  • low risk patients: initial follow-up CT at 6-12 months and then at 18-24 months if no change
  • high risk patients: initial follow-up CT at 3-6 months and then at 9-12 and 24 months if no change

Nodule size: >8 mm

  • either low or high risk patients
    • follow-up CTs at around 3, 9, and 24 months
    • dynamic contrast enhanced CT, PET, and/or biopsy 

Note: newly-detected indeterminate nodule in persons 35 years of age or older.

  • low risk patients: minimal or absent history of smoking and or other known risk factors
  • high risk patients: history of smoking or of other known risk factors (e.g. first degree relative with lung cancer, or exposure to asbestos, radon, uranium)
  • if a nodule up to 8 mm is partly solid or is ground glass further follow up is required after 24 months to exclude possible slow growing adenocarcinoma (BAC) 
Subsolid nodules
Solitary pure ground-glass nodules
  • nodule size ≤5 mm
    • no CT follow up required
  • nodule size >5 mm
    • follow up CT at 3 months, then annual CT for at least 3 years
Solitary part-solid nodules
  • initial follow-up CT at 3 months
  • if persistent and solid component <5 mm
    • annual CT for at least 3 years
  • if persistent and solid component ≥5 mm
    • biopsy or surgical resection
Multiple subsolid nodules
  • pure ground glass nodules ≤5 mm
    • CT at 2 and 4 years
  • pure ground glass nodules >5 mm, without a dominant lesion(s)
    • initial follow-up CT at 3 months then annual CT for at least 3 years
  • dominant nodule(s) with part-solid or solid component
    • initial follow-up CT at 3 months
    • if persistent, biopsy or surgical resection (especially if has >5 mm solid component)

See also

  • -<p>The <strong>Fleischner society pulmonary nodule recommendations</strong> are for the follow-up and management of <a href="/articles/pulmonary-nodule-1">pulmonary nodules</a> detected incidentally on imaging. The guideline does not apply to patients &lt;35 years or with a history of cancer or immunosuppression. The initial guideline was released in 2005 <sup>1</sup>, subsequently separate guideline for the management of subsolid nodules released in 2013 <sup>2</sup>. New revised 2017 recommendations for incidentally found solid and subsolid nodule or nodules have since been released <sup>4</sup>.</p><h4>2017 guidelines</h4><h5>Solid nodules</h5><h5>Solitary</h5><p><strong>Solitary nodule size: &lt;6 mm </strong></p><ul>
  • +<p>The <strong>Fleischner Society pulmonary nodule recommendations</strong> are for the follow-up and management of <a href="/articles/pulmonary-nodule-1">pulmonary nodules</a> detected incidentally on imaging. The guideline does not apply to patients &lt;35 years or with a history of cancer or immunosuppression. The initial guideline was released in 2005 <sup>1</sup>, subsequently separate guideline for the management of subsolid nodules released in 2013 <sup>2</sup>. New revised 2017 recommendations for incidentally found solid and subsolid nodule or nodules have since been released <sup>4</sup>.</p><h4>2017 guidelines</h4><h5>Solid nodules</h5><h5>Solitary</h5><p><strong>Solitary nodule size: &lt;6 mm </strong></p><ul>
  • +<li><a href="/articles/fleischner-society">Fleischner Society</a></li>

Updates to Link Attributes

Title was removed:
Fleischner society pulmonary nodule recommendations
Type was removed.
Visible was set to .

Updates to Primarylink Attributes

ADVERTISEMENT: Supporters see fewer/no ads

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.